Crossmark

Comparative safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis

Crossref DOI link: https://doi.org/10.1007/s00405-024-08517-z

Published Online: 2024-02-15

Published Print: 2024-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Shan

Yan, Li

Yu, Jing https://orcid.org/0000-0001-9521-261X
Lu, Cheng
License Information

Text and Data Mining valid from 2024-02-15

Version of Record valid from 2024-02-15
More Information

Article History

Received: 2 December 2023

Accepted: 29 January 2024

First Online: 15 February 2024

Declarations

:

: The authors declare no conflict of interest.

: This article does not include any studies involving humans or animals.

Document is current

Any future updates will be listed below